GCP Part 2 for NuCana

Welcome!

Welcome to the course resources page for Part 2 of the GCP Course. If you were unable to attend the live session you can view the video in the Course Content section at the bottom of this page. Once you have viewed the video your certificate will be available to download.

Feedback

Please take a moment to complete the feedback form below:

Course Handout

GCP Part 2 2021 ho

In answer to the question which was raised during the course regarding Information on GMP for N Ireland:
From what I can see the Northern Ireland protocol currently allows for a loophole in the QP release issue which means that you can import to and export from Northern Ireland under the either the UK or EU QP rules, so if your QP is in N Ireland you don’t need a re-certification in the EU. Whether this will remain the case is uncertain. Links to some relevant documents are below:
https://www.gov.uk/guidance/supplying-investigational-medicinal-products-to-northern-ireland
https://www.ema.europa.eu/en/documents/other/questions-answers-stakeholders-implementation-protocol-ireland/northern-ireland_en.pdf

https://www.appliedclinicaltrialsonline.com/view/consequences-of-brexit-for-clinical-trials-in-europe
This document says: “For the export of IMPs from Great Britain to the EU, on the other hand, sponsors must organize a new importer and batch releaser, plus a new QP declaration. The only workaround for this is to have the IMP manufactured in Northern Ireland and then ship it to the EU, as it is then not considered an imported IMP under the Northern Ireland Protocol.”